A detailed history of Amundi transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Amundi holds 46,614 shares of VIR stock, worth $342,146. This represents 0.0% of its overall portfolio holdings.

Number of Shares
46,614
Previous 14,373 224.32%
Holding current value
$342,146
Previous $107,000 219.63%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 07, 2025

BUY
$6.74 - $10.17 $217,304 - $327,890
32,241 Added 224.32%
46,614 $342,000
Q3 2024

Nov 13, 2024

BUY
$7.26 - $10.7 $10,933 - $16,114
1,506 Added 11.7%
14,373 $107,000
Q2 2024

Aug 14, 2024

SELL
$7.63 - $12.66 $18,411 - $30,548
-2,413 Reduced 15.79%
12,867 $114,000
Q1 2024

May 15, 2024

BUY
$8.6 - $11.9 $37,986 - $52,562
4,417 Added 40.66%
15,280 $154,000
Q3 2023

Nov 14, 2023

BUY
$9.14 - $24.62 $10,054 - $27,082
1,100 Added 11.27%
10,863 $101,000
Q2 2023

Aug 14, 2023

BUY
$23.2 - $27.29 $226,501 - $266,432
9,763 New
9,763 $239,000
Q2 2021

Aug 16, 2021

BUY
$38.75 - $51.0 $148,877 - $195,942
3,842 New
3,842 $182,000

Others Institutions Holding VIR

About Vir Biotechnology, Inc.


  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $974M
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track Amundi Portfolio

Follow Amundi and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

News

Stay updated on Amundi with notifications on news.